Another recent study demonstrated that enhanced IGFBP-7 expression promoted resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cells by mediating the IGF-1R pathway [97]. This evidence concerns the gene IGFBP7 and lung carcinoma.